Helena Laboratories, Inc. recalls Cascade Abrazo c-ACT-LR Test Card IVD FOR IN VITRO DIAGNOSTIC USE Store at 2 to 8 C HELENA LABORATORIES 003366 12/13(2)…
- Recall date
- April 20, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0594-2019
- FDA classification
- Class II
- Brand / firm
- Helena Laboratories, Inc.
- Sold / distributed
- US Distribution to state of TX and internationally to: Australia, Netherlands, Italy, and England.
Why it was recalled
Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Cascade Abrazo c-ACT-LR Test Card IVD FOR IN VITRO DIAGNOSTIC USE Store at 2 to 8 C HELENA LABORATORIES 003366 12/13(2) FOR EXPORT ONLY The Cascade Abrazo c-ACT-LR test cards are activated clotting time tests to be used with the Cascade Abrazo analyzer and are intended to monitor the effect of low to moderate heparin on coagulation in fresh whole blood.
Get recall alerts
Free email alert whenever Helena Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Helena Laboratories, Inc.